 PHILADELPHIA, July 12, 2021 PRNewswire -- Lannett Company, Inc. NYSE: LCI today announced that it recently began marketing Fluvastatin Sodium Extended-release Tablets, 80 mg, a partnered product. Total U.S. sales of Fluvastatin Sodium Extended-release Tablets, 80 mg, according to IQVIA market, were approximately 10 million for the 12 months ending May 2021, although actual generic market values are expected to be lower. 